A study of Fermaglich and Miller (2023) evaluated trends in orphan drug designations and approvals after the Orphan Drug ...
Why is it so difficult to estimate the value of orphan drugs indicated for the treatment of rare diseases? There are a ...
A study of Fermaglich and Miller (2023) evaluated trends in orphan drug designations and approvals after the Orphan Drug ...
Why is it so difficult to estimate the value of orphan drugs indicated for the treatment of rare diseases? There are a ...